乳腺癌治疗与卵巢功能
本文更新了乳腺癌幸存者化疗后卵巢功能及性腺损伤机制。烷化剂对原始和生长卵泡均有毒性,抗代谢药更易破坏腔前和腔卵泡。年轻患者卵巢储备较高,更可能保留部分卵巢功能,但同龄患者间储备差异大,卵巢储备严重下降者仍可规律月经,故年龄和月经状态不可靠,应结合窦卵泡计数和抗苗勒管激素评估并考虑生育力保存。
要点
- 烷化剂对原始和生长卵泡均有毒性,抗代谢药更易破坏腔前和腔卵泡。
- 年轻患者卵巢储备较高,更可能保留部分卵巢功能,但同龄患者间差异显著。
- 卵巢储备严重下降者仍可规律月经,年龄和月经状态不可靠,应结合窦卵泡计数和抗苗勒管激素评估。
核心结论
- 年龄和月经状态不是卵巢储备良好的可靠指标,可能造成虚假安全感,若未考虑更可靠的定量标志物(窦卵泡计数和抗苗勒管激素)并未进行生育力保存,可能导致不良结局。
研究设计与样本
- 本文为综述,旨在更新乳腺癌幸存者化疗后卵巢功能及性腺损伤机制。
主要发现
- 烷化剂对原始和生长卵泡均有毒性;抗代谢药更易破坏腔前和腔卵泡。
- 年轻患者卵巢储备较高,更可能保留部分卵巢功能,但同龄患者间卵巢储备差异显著。
- 卵巢储备严重下降的患者仍可规律月经。
- 关于含紫杉类新方案对卵巢功能影响的数据仅在过去十年积累,靶向治疗对卵巢功能影响的数据仍非常有限。
局限性
- 关于含紫杉类新方案对卵巢功能影响的数据仅在过去十年积累,数据仍非常有限。
- 关于靶向治疗对卵巢功能影响的数据仍非常有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The aim of this study was to provide an update on ovarian function and the mechanisms of gonadal damage after exposure to chemotherapy in breast cancer survivors. The alkylating agents are toxic to both primordial and growing follicles. However, anti-metabolite drugs are more likely to destroy preantral and antral follicles. Younger patients are more likely to have a higher ovarian reserve, and therefore, more likely to retain some residual ovarian function after exposure to gonadotoxic regimens. However, there can be significant variability in ovarian reserve among patients of the same age. Furthermore, patients with critically diminished ovarian reserve may continue to menstruate regularly. Therefore age and menstrual status are not reliable indicators of good ovarian reserve and might give a false sense of security and result in an adverse outcome if the patient is consulted without considering more reliable quantitative markers of ovarian reserve (antral follicle count and anti-Müllerian hormone) and fertility preservation is not pursued. In contrast to well-documented ovarian toxicity of older chemotherapy regimens, data for newer taxane-containing protocols have only accumulated in the last decade and data are still very limited regarding the impact of targeted therapies on ovarian function.
引用
- Yildiz S, Bildik G, Benlioglu C, et al. Breast cancer treatment and ovarian function. Reprod Biomed Online. 2022. PMID: 36400663. doi:10.1016/j.rbmo.2022.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。